These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

58 related articles for article (PubMed ID: 19701545)

  • 21. Antithrombotics in acute coronary syndromes.
    Bonaca MP; Steg PG; Feldman LJ; Canales JF; Ferguson JJ; Wallentin L; Califf RM; Harrington RA; Giugliano RP
    J Am Coll Cardiol; 2009 Sep; 54(11):969-84. PubMed ID: 19729112
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prasugrel: new drug. After angioplasty and stenting: continue to use aspirin + clopidogrel.
    Prescrire Int; 2009 Oct; 18(103):193-5. PubMed ID: 19877380
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Tirofiban--an overview of the phase III trials.
    Herrmann HC
    J Invasive Cardiol; 1999 Dec; 11 Suppl C():7C-13C. PubMed ID: 10745615
    [No Abstract]   [Full Text] [Related]  

  • 24. Statins in acute coronary syndromes: do the guideline recommendations match the evidence?
    Morrissey RP; Diamond GA; Kaul S
    J Am Coll Cardiol; 2009 Oct; 54(15):1425-33. PubMed ID: 19796735
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The transmembrane structure of integrin alphaIIbbeta3: significance for signal transduction.
    Hoefling M; Kessler H; Gottschalk KE
    Angew Chem Int Ed Engl; 2009; 48(36):6590-3. PubMed ID: 19598189
    [No Abstract]   [Full Text] [Related]  

  • 26. Relation of troponin I levels following nonemergent percutaneous coronary intervention to short- and long-term outcomes.
    Feldman DN; Minutello RM; Bergman G; Moussa I; Wong SC
    Am J Cardiol; 2009 Nov; 104(9):1210-5. PubMed ID: 19840564
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The 5-year clinical outcomes after a randomized comparison of sirolimus-eluting versus bare-metal stent implantation in patients with ST-segment elevation myocardial infarction.
    Tebaldi M; Arcozzi C; Campo G; Percoco G; Ferrari R; Valgimigli M;
    J Am Coll Cardiol; 2009 Nov; 54(20):1900-1. PubMed ID: 19892243
    [No Abstract]   [Full Text] [Related]  

  • 28. Percutaneous coronary intervention-related time delay, patient's risk profile, and survival benefits of primary angioplasty vs lytic therapy in ST-segment elevation myocardial infarction.
    De Luca G; Cassetti E; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):712-9. PubMed ID: 19751630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perioperative strokes and beta-blockade.
    Poldermans D; Schouten O; van Lier F; Hoeks SE; van de Ven L; Stolker RJ; Fleisher LA
    Anesthesiology; 2009 Nov; 111(5):940-5. PubMed ID: 19786861
    [No Abstract]   [Full Text] [Related]  

  • 30. [The GOSPEL study].
    Volterrani M; Agostoni P
    G Ital Cardiol (Rome); 2009 Jul; 10(7):419-21. PubMed ID: 19761099
    [No Abstract]   [Full Text] [Related]  

  • 31. [Statins in practice of the vascular surgeon and cardiologist].
    PokrovskiÄ­ AV; Suntsov DS
    Angiol Sosud Khir; 2009; 15(2):123-7. PubMed ID: 19806952
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Prehospital assessment and treatment decisions of a suspected acute coronary syndrome: what are the problems? Results of the "Emergency Doctor and Acute Myocardial Infarction" study (NAAMI)].
    Ohlow MA; Schreiber M; Lauer B
    Dtsch Med Wochenschr; 2009 Oct; 134(40):1984-9. PubMed ID: 19777412
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effectiveness of tirofiban for failed thrombolysis during acute myocardial infarction.
    Vetrano A; Carotenuto R; Corsini F; Schioppa M; Martone A; Melorio S; Sideri F; Romano S; Chieffo C; Corsini G
    Am J Cardiol; 2004 Apr; 93(7):914-6. PubMed ID: 15050497
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Glycoprotein IIb/IIIa inhibition and long-term benefit: the stuff of dreams?
    Montalescot G
    Eur Heart J; 2004 Sep; 25(18):1562-4. PubMed ID: 15351154
    [No Abstract]   [Full Text] [Related]  

  • 35. Facilitated angioplasty with combo therapy among patients with ST-segment elevation myocardial infarction: a meta-analysis of randomized trials.
    De Luca G; Marino P
    Am J Emerg Med; 2009 Jul; 27(6):683-90. PubMed ID: 19751625
    [TBL] [Abstract][Full Text] [Related]  

  • 36. FX-06, a fibrin-derived Bbeta15-42 peptide for the potential treatment of reperfusion injury following myocardial infarction.
    Ahrens I; Peter K
    Curr Opin Investig Drugs; 2009 Sep; 10(9):997-1003. PubMed ID: 19705343
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Earlier administration of high-dose bolus tirofiban in STEMI increases benefit without increasing bleeding complications.
    Cardiovasc J Afr; 2009; 20(4):268. PubMed ID: 19701545
    [No Abstract]   [Full Text] [Related]  

  • 38. Current strategies with high-dose tirofiban.
    Mukherjee D; Roffi M
    Expert Opin Drug Metab Toxicol; 2007 Apr; 3(2):275-80. PubMed ID: 17428156
    [TBL] [Abstract][Full Text] [Related]  

  • 39.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 3.